Kytopen

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a cell engineering platform designed to offer healthy and functional cells. Kytopen is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $47 million in Sep 2024. It has raised $52.9 million across 5 recorded rounds; the latest was a $7.1 million early-stage round in Feb 2025.

Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$52.9M
Last round
Early Stage VC
Feb 2025
How much has Kytopen raised?
$52.9Macross 5 recorded rounds · May 2019 – Feb 2025

Most recently, Kytopen raised $7.1M in its Early Stage VC (Feb 2025).

Free account
More of Kytopen with a free account
  • ·The complete investor list: 16 names
  • ·Watch Kytopen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kytopen round by round

5 rounds
Feb 2025Early Stage VC$7.1MSEC filing▮
13 investors participated
Jan 2024Early Stage VC$5.7MSEC filing▮
22 investors participated
Sep 2021Early Stage VC$32.5MSEC filing▮
18 investors participated
Oct 2020Seed Round$3.1MSEC filing▮
11 investors participated
May 2019Seed Round$4.3MSEC filing▮
9 investors participated

How much has Kytopen raised?

Kytopen has raised $52.9 million across 5 recorded rounds since 2019. The largest was a $7.1 million early-stage round in Feb 2025.

Kytopen has filed 5 Form Ds with the SEC since 2019, most recently in Feb 2025 ($7.1 million sold to 13 investors).

Kytopen investors

16 investors are on record for Kytopen, including US National Science Foundation, National Institutes of Health, Alexandria Venture Investments and The Engine. The early-stage round in Feb 2025 drew 13 investors.

For fundraisers
Raising for a company like Kytopen?

16 investors have backed Kytopen.

See all 16 investors →

Frequently asked about Kytopen

How much has Kytopen raised?
Kytopen has raised $52.9M in total across 5 recorded funding rounds.
When was Kytopen's last funding round?
Kytopen's most recent recorded round was Early Stage VC in Feb 2025, raising $7.1M.